NIH-funded research R01 grant

Investigating how calcium channels affect Alzheimer's disease

Official title: L-type calcium channels in Alzheimer’s disease pathophysiology

Funded at University of Texas Hlth Science Center · NIH-11160794 · Data updated 2026-11-12

This study is looking at how certain calcium channels in the brain might affect the progression of Alzheimer's disease, and it hopes to find new ways to protect brain cells and improve treatment options for people with the condition.

More s Disease research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Texas Hlth Science Center
NIH-funded
Lab location1 site (San Antonio, United States)
Project startAugust 15, 2024
Project endMay 31, 2029
Funding year2025
Award (this year)$563,501
NIH project number5R01AG085531-02
Project IDNIH-11160794 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals at risk for Alzheimer's disease or those experiencing early symptoms of cognitive decline.

Less likely to help

Patients with advanced Alzheimer's disease or those with other forms of dementia may not benefit from this research.

What this research studies

This research explores the role of L-type calcium channels in the development and progression of Alzheimer's disease. It aims to understand how these channels contribute to calcium dysregulation, which is linked to cognitive decline and tau pathology. By using specific animal models, the researchers will evaluate the effects of calcium channel antagonists on cellular dysfunction related to amyloid plaques and neuroinflammation. The study seeks to uncover potential neuroprotective mechanisms that could lead to new therapeutic strategies for Alzheimer's patients.

Why it matters

Potential benefit: If successful, this research could lead to new treatments that protect against cognitive decline in Alzheimer's disease.

How similar studies have gone: Previous research has shown promising results with calcium channel antagonists in reducing Alzheimer's pathology, indicating potential for success in this approach.

Where this research is happening

  • University of Texas Hlth Science Center
    San Antonio, United States
    Active

Researchers

  • Principal investigator: Hopp, Sarah Christine — University of Texas Hlth Science Center
  • Study coordinator: Hopp, Sarah Christine

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.